South Korea to purchase 70,000 projects of most recent Pfizer COVID-19 case
SEOUL – South Korea has agreed to buy 70,000 courses of Pfizer Inc.’s experimental antiviral COVID-19 pill, the Korea Disease Control and Prevention Agency (KDCA) said over the weekend.
Pfizer on Friday said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in patients at high risk of severe illness within...
If it ain’t broke, don’t fix it
“Different countries were interested in our stock exchange,” reminisces former Securities and Exchange Commission chairman Khalid Mirza. “I met a representative, who I will not name, in Karachi. He was willing to come here, but under one condition: he will provide the system.”
Last week, Pakistan Stock Exchange (PSX) implemented the new trading system that...
Creators lost their balance after Pfizer’s COVID-19 antiviral tablet affirmed promising viability in a preliminary.
Hong Kong stocks declined for a second day with tech firms leading losers as the Chinese Communist Party kicked off a key meeting in Beijing under a cloud of economic slowdown.
The Hang Seng Index retreated 0.4 per cent to 24,763.77 at the close of Monday trading. The Hang Seng Tech Index slid 1.3 per cent, while...
